FRANCO MIGLIACCIO, ANNA RITA
 Distribuzione geografica
Continente #
AS - Asia 1.726
EU - Europa 113
NA - Nord America 111
AF - Africa 3
OC - Oceania 3
SA - Sud America 1
Totale 1.957
Nazione #
SG - Singapore 1.589
US - Stati Uniti d'America 109
HK - Hong Kong 80
CN - Cina 54
GB - Regno Unito 33
IT - Italia 30
NL - Olanda 15
DE - Germania 11
FI - Finlandia 10
ES - Italia 7
AU - Australia 3
UA - Ucraina 3
ZA - Sudafrica 3
CA - Canada 2
FR - Francia 2
JP - Giappone 2
BR - Brasile 1
EE - Estonia 1
IN - India 1
LT - Lituania 1
Totale 1.957
Città #
Hong Kong 80
Singapore 47
Boardman 37
London 31
Hefei 24
Ashburn 22
Shanghai 17
Amsterdam 14
Rome 13
Helsinki 8
Los Angeles 7
Munich 7
Council Bluffs 4
Granada 4
Bologna 3
Melbourne 3
Santa Clara 3
Seattle 3
Beijing 2
Boston 2
Brooklyn 2
Johannesburg 2
Newark 2
San Francisco 2
Tokyo 2
Toronto 2
Turin 2
Turku 2
Buffalo 1
Carignano 1
Cascina 1
Charlotte 1
Chongqing 1
Guangzhou 1
Hanover 1
Jiaxing 1
Madrid 1
Milan 1
Naples 1
New Delhi 1
New York 1
Paris 1
Phoenix 1
Providence 1
Secaucus 1
Shenyang 1
Shenzhen 1
São Paulo 1
Vilnius 1
Totale 368
Nome #
Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1low model of myelofibrosis 193
Increased differentiation of dermal mast cells in mice lacking the Mpl gene 184
Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1low mouse model 170
Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion 161
Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis 139
single cell analysis of the localization of the heamatopoietic stem cells within the bone marrow architecture identifies niche-specific proliferation dynamics 93
Dexamethasone Predisposes Human Erythroblasts Toward Impaired Lipid Metabolism and Renders Their ex vivo Expansion Highly Dependent on Plasma Lipoproteins 86
CXCR4-Independent Rescue of the Myeloproliferative Defect of the Gata1low Myelofibrosis Mouse Model by Aplidin® 83
Removal of the spleen in mice alters the cytokine expression profile of the marrow micro-environment and increases bone formation 83
A Novel Megakaryocyte Subpopulation Poised to Exert the Function of HSC Niche as Possible Driver of Myelofibrosis 80
Patients with hypercortisolemic Cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis 77
Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis 76
Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology 76
Novel targets to cure primary myelofibrosis from studies on Gata1low mice 76
hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1 low Mutation in Mice 73
Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in Gata1low Mice 71
Role of β1 integrin in thrombocytopoiesis 69
P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis 61
CXCL8/CXCR2 signaling mediates bone marrow fibrosis and is a therapeutic target in myelofibrosis 40
The thrombopoietin/MPL axis is activated in the Gata1low mouse model of myelofibrosis and is associated with a defective RPS14 signature 23
The Glucocorticoid Receptor Polymorphism Landscape in Patients With Diamond Blackfan Anemia Reveals an Association Between Two Clinically Relevant Single Nucleotide Polymorphisms and Time to Diagnosis 20
The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 low Mice 19
TGF-β1 protein trap AVID200 beneficially affects hematopoiesis and bone marrow fibrosis in myelofibrosis 19
Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1low model of myelofibrosis 15
A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis 1
Totale 1.988
Categoria #
all - tutte 7.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.800


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 0 0 0 0 0 0 5 0 0 0 10
2022/202326 0 0 0 1 3 0 0 0 0 0 6 16
2023/2024102 8 15 5 19 7 32 3 2 3 7 0 1
2024/20251.845 24 3 25 16 6 27 46 5 40 127 646 880
Totale 1.988